China South Korea Usa India Indonesia Pakistan Denmark Bangladesh Norway South Africa Kenya Jordan Vietnam Egypt county Charles covid-19 reports Merck China South Korea Usa India Indonesia Pakistan Denmark Bangladesh Norway South Africa Kenya Jordan Vietnam Egypt county Charles

Generic drug makers sign on to make Merck COVID-19 antiviral

Reading now: 857

Following an initial licensing deal in October between the United Nations–based Medicines Patent Pool (MPP) and Merck to allow pharmaceutical companies in other countries to make molnupiravir, an oral antiviral for treating COVID-19, the MPP today announced agreements with 27 generic makers.In other global developments, Denmark and Norway are among the countries reporting quickly rising levels of an Omicron subvariant, but it's not yet known if it will have an impact on the clinical picture or tools to fight the virus.Generic makers hail from 11 countriesIn a statement, the MPP said the agreements with drug firms pave the way for 105 low- and middle-income countries (LMICs) to access to the drug.

Clinical studies suggest the drug can cut the risk of hospitalization and death from COVID-19 by 30%.In December, the US Food and Drug Administration (FDA) authorized the drug for emergency use.

Merck has said it expects the drug is effective against the Omicron variant.The MPP said the agreements with the companies cover production of raw ingredients and/or the finished drug.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Gojira reschedule UK and European tour due to COVID-19 - - Switzerland - Germany - Britain - Ireland - France - city Berlin - Netherlands - Denmark - city Dublin - county Hall - county Forest - city Budapest - Belgium - city Prague - city Milan - city Stockholm - city Oslo - county Lyon - city Helsinki - city Copenhagen
Gojira reschedule UK and European tour due to COVID-19
Gojira have rescheduled their upcoming UK and European tour due to COVID-19 restrictions.The French metal titans were supposed to hit the road last month, beginning in Helsinki, with stop-offs in Oslo, Stockholm, Copenhagen, Berlin, Prague, Budapest and other cities throughout January into February and March.However, they’ve announced that they will now kick off their European tour on July 5 in Brussels and conclude it in Milan on July 31 at Carroponte.The UK and Ireland leg of the tour, meanwhile, has moved to 2023 and will begin on February 11 in Dublin and conclude at London’s Alexandra Palace on February 22.Gojira will then play rescheduled shows in Bordeaux, Paris, Luxembourg and Lyon between February 24 and 28, 2023.“We cannot express how much we appreciate your continued patience and support while we worked through last month’s postponement,” the band said in a social media post.“Despite our best efforts to resume touring this month, the continued uncertainty in various territories has left us with no other choice but to reschedule the remaining dates of the tour as well.“In light of this unfortunate news we are pleased to share the rescheduled dates for the entire European Tour below.”A post shared by Gojira Official (@gojiraofficial)Original tickets for the tour – which sees support from special guests Alien Weaponry and Employed To Serve – remain valid.
New projections indicate number of COVID-19 patients in Quebec will continue to drop -
New projections indicate number of COVID-19 patients in Quebec will continue to drop
COVID-19 hospitalizations in Quebec is expected to continue to decline over the next two weeks, a government health-care research institute projected Wednesday.By the end of the month, the number of people in Quebec hospitals with COVID-19 should drop by about 500, to 1,500 patients, according to the Institut national d’excellence en santé et services sociaux. There should be about half the number of intensive care patients by that time, or about 60, it added.“For all of Quebec, the projections suggest a slight decrease in new hospitalizations,” INESSS said in a news release, adding that it expected the number of new hospitalizations to reach around 90 per day within the next two weeks.The research institute said its projections should be interpreted with caution as it cannot forecast the effect of changes to COVID-19 restrictions. Quebec reopened gyms and spas on Monday, shortly after lifting restrictions on private gatherings and limits on the number of people who can dine together at restaurants.A separate health-care research institute said Wednesday that preliminary results from a vaccine study indicate three doses of COVID-19 vaccine offer more protection compared with two doses against severe and mild forms of the disease caused by the Omicron variant.“The effectiveness is highest against serious COVID-19 infections — those that lead to hospitalizations,” the Institut national de santé publique du Quebec said in a news release.